verbio Vereinigte BioEnergie AG (DE:VBK)
XETRA:VBK
Want to see DE:VBK full AI Analyst Report?
Top Page
verbio Vereinigte BioEnergie
(XETRA:VBK)
Select Model
Select Model
Rating:56Neutral
Price Target:
€36.00
▲(1.41% Upside)
Action:Reiterated
Date:05/17/26
The score is held back primarily by weak and volatile recent profitability (thin margins and TTM losses) despite an acceptable balance sheet and improving but inconsistent cash generation. Offsetting this, the earnings call points to strong operational momentum with EBITDA tracking toward the top end of guidance alongside improving cash flow and deleveraging, and the technical picture is favorable with the stock trading above key moving averages. Valuation is a mild headwind given the higher P/E and modest dividend yield.
Positive Factors
Diversified renewable-fuel portfolio
VERBIO’s vertically integrated production across bioethanol, biodiesel and biomethane plus sale of co-products provides structural revenue diversification. Multiple physical products and by‑products reduce single-market dependence, support margin mix flexibility and align with long‑term decarbonization demand.
Negative Factors
Thin margins and recent losses
Margins remain pressured after recent deterioration, with TTM gross margin near single digits and negative net income. Persistent thin margins reduce buffer against feedstock or energy cost shocks, limiting sustainable profitability and making multi‑period earnings recovery vulnerable to adverse commodity or operational shifts.
Read all positive and negative factors
Positive Factors
Negative Factors
Diversified renewable-fuel portfolio
VERBIO’s vertically integrated production across bioethanol, biodiesel and biomethane plus sale of co-products provides structural revenue diversification. Multiple physical products and by‑products reduce single-market dependence, support margin mix flexibility and align with long‑term decarbonization demand.
Read all positive factors
verbio Vereinigte BioEnergie (VBK) vs. iShares MSCI Germany ETF (EWG)
Market Cap
€2.26B
Dividend Yield1.02%
Average Volume (3M)165.84K
Price to Earnings (P/E)31.7
Beta (1Y)0.69
Revenue Growth19.36%
EPS Growth-133.76%
CountryDE
Employees1,521
SectorGeneral
Sector StrengthN/A
IndustryOil & Gas Energy
Share Statistics
EPS (TTM)-1.18
Shares Outstanding63,715,480
10 Day Avg. Volume196,028
30 Day Avg. Volume165,844
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)1.04
Price to Sales (P/S)0.49
P/FCF Ratio-6.59
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€39.00Price Target Upside9.86% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)0.67
Revenue Forecast (FY)€1.79B
verbio Vereinigte BioEnergie Business Overview & Revenue Model
Company Description
VERBIO Vereinigte BioEnergie AG produces and supplies biofuels in Germany and rest of Europe. The company's products include biodiesel, bioethanol, biomethane, biosterol, bioglycerin, and liquid fertilizers. The company offers its products to oil ...
How the Company Makes Money
VERBIO makes money primarily by producing and selling renewable fuels and monetizing co-products from its biofuel production processes. Key revenue streams include: (1) Sales of liquid biofuels: VERBIO sells bioethanol and biodiesel into fuel mark...
verbio Vereinigte BioEnergie Earnings Call Summary
Earnings Call Date:May 13, 2026
(Q3-2026)
| % Change Since: |
Next Earnings Date:Sep 24, 2026
Earnings Call Sentiment Positive
The call conveys a positive operational and financial momentum: strong Q3 EBITDA acceleration, production ramp‑ups (notably ethanol/biomethane), robust operating cash‑flow and balance‑sheet improvement, plus material regulatory tailwinds (RED III and U.S. RVO) supporting medium‑term demand. These positives are tempered by temporary operational disruptions in Europe, early‑year negative U.S. ethanol margins, seasonal/structural changes at the Canadian plant, and ongoing geopolitical and commodity price volatility that create near‑term uncertainty. Management raised guidance to the top of the prior range but remains cautious about upside beyond that level.Positive Updates
Strong Q3 EBITDA and Large Sequential Improvement
Group EBITDA in Q3 reached EUR 60.2 million, up from EUR 8.2 million in Q3 last year (≈+634% year‑over‑year) and up from EUR 30.1 million in the prior quarter (≈+100% quarter‑over‑quarter). The Bioethanol/Biomethane segment was the main driver of the Q3 improvement.
Negative Updates
Temporary Biological/Operational Disruptions in Europe
Fermentation/biological issues in Europe temporarily affected production in Q3; management stated the issues were resolved by mid‑April but they depressed quarterly ethanol volumes.
Read all updates
Q3-2026 Updates
Positive
Negative
Strong Q3 EBITDA and Large Sequential Improvement
Group EBITDA in Q3 reached EUR 60.2 million, up from EUR 8.2 million in Q3 last year (≈+634% year‑over‑year) and up from EUR 30.1 million in the prior quarter (≈+100% quarter‑over‑quarter). The Bioethanol/Biomethane segment was the main driver of the Q3 improvement.
Read all positive updates
Company Guidance
Management reiterated it now expects full-year EBITDA at the upper end of the range it set in March (EUR 100–140 million), i.e., toward EUR 140 million, supported by Q3 group EBITDA of EUR 60.2 million (Q3 biodiesel EBITDA EUR 18.5 million; bioethanol/biomethane EBITDA EUR 34.2 million) and strong market/backlog dynamics; they noted only roughly an additional EUR 34 million would be needed in Q4 to hit the top end. Year‑to‑date liquidity and leverage metrics are improving: operating cash flow after nine months EUR 96.4 million, PPE investments EUR 63.4 million, positive free cash flow EUR 33 million, net debt reduced to EUR 126.8 million and now expected to be below EUR 140 million at year‑end with net debt/EBITDA targeted below 1. Operational metrics cited include biodiesel output ~458,000 tonnes (first half), bioethanol production ~431,000 tonnes and biomethane >1 TWh after nine months, and management highlighted that a EUR 100 rise in GHG‑quota prices would affect annual EBITDA by about EUR 40–80 million.verbio Vereinigte BioEnergie Financial Statement Overview
Summary
Income Statement
38
Negative
Balance Sheet
62
Positive
Cash Flow
44
Neutral
| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.77B | 1.58B | 1.67B | 1.97B | 1.81B | 1.03B |
| Gross Profit | 124.61M | 37.12M | 292.45M | 381.91M | 626.92M | 271.64M |
| EBITDA | 90.17M | -54.41M | 122.92M | 242.68M | 494.81M | 166.48M |
| Net Income | -75.05M | -138.01M | 19.96M | 132.02M | 315.63M | 93.20M |
Balance Sheet | ||||||
| Total Assets | 1.30B | 1.28B | 1.38B | 1.30B | 1.13B | 678.62M |
| Cash, Cash Equivalents and Short-Term Investments | 54.87M | 64.41M | 126.70M | 170.31M | 300.50M | 105.34M |
| Total Debt | 227.57M | 268.86M | 194.20M | 189.97M | 49.39M | 46.48M |
| Total Liabilities | 527.34M | 536.78M | 449.54M | 385.36M | 310.16M | 168.75M |
| Stockholders Equity | 768.78M | 746.29M | 925.67M | 909.47M | 816.23M | 507.85M |
Cash Flow | ||||||
| Free Cash Flow | 22.50M | -117.96M | -54.38M | -177.12M | 210.15M | 49.90M |
| Operating Cash Flow | 121.79M | 13.88M | 116.78M | 26.09M | 325.03M | 117.18M |
| Investing Cash Flow | -88.86M | -120.06M | -144.90M | -266.43M | -113.62M | -46.56M |
| Financing Cash Flow | -48.66M | 49.88M | -19.53M | 112.21M | -18.48M | -18.76M |
verbio Vereinigte BioEnergie Technical Analysis
Negative
35.50
Price Trends
37.95
Negative
31.22
Positive
22.55
Positive
Market Momentum
-0.16
Positive
45.79
Neutral
39.25
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DE:VBK, the sentiment is Negative. The current price of 35.5 is below the 20-day moving average (MA) of 37.48, below the 50-day MA of 37.95, and above the 200-day MA of 22.55, indicating a neutral trend. The MACD of -0.16 indicates Positive momentum. The RSI at 45.79 is Neutral, neither overbought nor oversold. The STOCH value of 39.25 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for DE:VBK.
verbio Vereinigte BioEnergie Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | €4.45B | 13.32 | 16.38% | 3.91% | 0.03% | 5.54% | |
64 Neutral | €7.89B | 15.61 | 1.89% | 8.92% | -9.37% | -47.49% | |
63 Neutral | €8.49B | 21.10 | 5.27% | 4.30% | -9.48% | -56.88% | |
56 Neutral | €2.26B | 31.72 | -10.00% | 1.02% | 19.36% | -133.76% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
53 Neutral | €4.80B | 100.12 | -20.12% | 3.75% | ― | ― | |
49 Neutral | €1.46B | -2.86 | -17.77% | 0.59% | -14.31% | -386.04% |
* General Sector Average
DE:VBK
verbio Vereinigte BioEnergie
35.40
25.73
266.08%
DE:BNR
Brenntag AG
58.82
0.39
0.66%
DE:EVK
Evonik
16.93
-2.18
-11.42%
DE:FPE
Fuchs Petrolub
30.95
-1.53
-4.70%
DE:LXS
LANXESS
16.96
-9.22
-35.22%
DE:WCH
Wacker Chemie AG
96.70
33.20
52.28%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.